ResearcherTianjin Medical University Cancer Institute and HospitalNo recent work listed

Maoyuan Li

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5102347502. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper

Papers 1

MicroRNA-608 promotes apoptosis via BRD4 downregulation in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2019.11246 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Weidong Ma · 1 shared paper, 2020 · strength 0.15
- Paper MicroRNA-608 promotes apoptosis via BRD4 downregulation in pancreatic ductal adenocarcinoma. DOI 10.3892/ol.2019.11246 ↗
Xiuchao Wang · 1 shared paper, 2020 · strength 0.15
- Paper MicroRNA-608 promotes apoptosis via BRD4 downregulation in pancreatic ductal adenocarcinoma. DOI 10.3892/ol.2019.11246 ↗
Gang Zhao · 1 shared paper, 2020 · strength 0.15
- Paper MicroRNA-608 promotes apoptosis via BRD4 downregulation in pancreatic ductal adenocarcinoma. DOI 10.3892/ol.2019.11246 ↗
Ting Li · 1 shared paper, 2020 · strength 0.15
- Paper MicroRNA-608 promotes apoptosis via BRD4 downregulation in pancreatic ductal adenocarcinoma. DOI 10.3892/ol.2019.11246 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.